CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Search

We found 6978 result(s)

indacaterol /mometasone furoate (Atectura Breezhaler)

Last Updated: August 31, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: indacaterol /mometasone furoate
Indications: Asthma maintenance (adults, children 12 or older)

  • Brand Name: Atectura Breezhaler
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0646-000
  • Project Status: Active
  • Submission Type: New

A statement from Suzanne McGurn, CADTH President and CEO, on International Overdose Awareness Day

Published on: August 31, 2020
Result type: News

International Overdose Awareness Day is a global day of awareness held every year on August 31. Today, I join millions of Canadians in reflecting on the lives lost due to overdose, the grief so many families endure, and the stigma that impacts the daily lives of people who use drugs. I’m also thinking about the social and economic disparities t...

CADTH Weekly COVID-19 Update

Last Updated: August 31, 2020
Result type: Reports
Product Line: New at CADTH

CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time. Our COVID-19 evidence portal contains the latest COVID-19 information from CADTH and other respected organizations. Content is updated daily to reflect the rapidly changing and growing state of the international scientific evidence...